OM Outset Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OM

Price (delayed)

$4.63

Market cap

$85.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.07

Enterprise value

$153.05M

?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 28
Relative Valuation: Rel. Valuation: 31
Relative Profitability: Rel. Profitability: 28

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to ...

Highlights
OM's EPS has surged by 86% year-on-year and by 24% since the previous quarter
The net income is up by 34% year-on-year and by 8% since the previous quarter
The equity has contracted by 34% YoY and by 12% from the previous quarter
OM's quick ratio is down by 26% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://outsetmedical.com
Peers: OBIO

Key stats

What are the main financial stats of OM

OM stock price

How has the Outset Medical stock price performed over time
Intraday
-2.73%
1 week
15.17%
1 month
7.18%
1 year
-76.82%
YTD
24.8%
QTD
20.57%

Financial performance

How have Outset Medical's revenue and profit performed over time
Revenue
$117.59M
Gross profit
$47.78M
Operating income
-$67.23M
Net income
-$74.85M
Gross margin
40.6%
Net margin
-63.7%
OM's net margin is up by 35% YoY and by 7% from the previous quarter
The net income is up by 34% year-on-year and by 8% since the previous quarter
The operating margin has grown by 29% year-on-year but it has declined by 2.5% since the previous quarter
Outset Medical's operating income has increased by 28% YoY

Price vs fundamentals

How does OM's price correlate with its fundamentals

Growth

What is Outset Medical's growth rate over time

Valuation

What is Outset Medical stock price valuation
P/E
N/A
P/B
0.76
P/S
0.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.3
OM's EPS has surged by 86% year-on-year and by 24% since the previous quarter
OM's price to book (P/B) is 75% lower than its 5-year quarterly average of 3.1 and 42% lower than its last 4 quarters average of 1.3
The equity has contracted by 34% YoY and by 12% from the previous quarter
OM's price to sales (P/S) is 90% lower than its 5-year quarterly average of 7.5 and 52% lower than its last 4 quarters average of 1.5
Outset Medical's revenue has increased by 2% YoY

Efficiency

How efficient is Outset Medical business performance
Outset Medical's ROE has soared by 62% YoY
OM's return on sales is up by 36% year-on-year and by 9% since the previous quarter
Outset Medical's return on assets has increased by 28% YoY and by 4.2% QoQ
The return on invested capital has increased by 20% year-on-year and by 10% since the previous quarter

Dividends

What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OM.

Financial health

How did Outset Medical financials performed over time
The total assets is 81% greater than the total liabilities
OM's quick ratio is down by 26% year-on-year and by 7% since the previous quarter
The current ratio has declined by 25% year-on-year and by 6% since the previous quarter
OM's debt is 9% less than its equity
The debt to equity has surged by 57% year-on-year and by 14% since the previous quarter
The equity has contracted by 34% YoY and by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.